Results 31 to 40 of about 917 (132)

Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study [PDF]

open access: yes, 2018
BackgroundIn recent years, several biosimilar drugs, including those of infliximab, have obtained marketing authorization from the European Medicines Agency (EMA). Given the peculiarity of the safety profile of biological medical products (originator and
A. Capuano   +8 more
core   +1 more source

MOBILITY ATLAS BOOKLET: AN URBAN DASHBOARD DESIGN AND IMPLEMENTATION [PDF]

open access: yes, 2018
. The new data sources give the possibility to answer analytically the questions that arise from mobility manager. The process of transforming raw data into knowledge is very complex, and it is necessary to provide metaphors of visualizations that are ...
D. Fadda   +4 more
core   +2 more sources

UEG Week 2025 Moderated Posters

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
wiley   +1 more source

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Home - About - Disclaimer - Privacy